Guidant wants J&J to refund breakup fee

Broken engagements can be so acrimonious. When Guidant bowed out of its takeover by Johnson & Johnson to hook up with Boston Scientific, it paid J&J a $715 million breakup fee. Now Guidant wants that money back.

You'll recall that J&J sued for $5.5 billion in damages from that failed deal, claiming that Guidant breached its agreement not to entertain other suitors. Guidant has filed a counterclaim in that suit, saying it didn't breach their contract--and even if it had, it doesn't owe J&J the termination fee.

- read the report from the Star Tribune

Related Articles:
J&J may drop Guidant deal. Report
Guidant, Boston Scientific sign deal. Report
Guidant bid deadline approaches for J&J. Report

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.